Jerome Zeldis
2021 - NexImmune
In 2021, Jerome Zeldis earned a total compensation of $4.3M as EVP, Head of Research & Development at NexImmune.
Compensation breakdown
| Option Awards | $3,935,874 |
|---|---|
| Salary | $396,017 |
| Other | $9,773 |
| Total | $4,341,664 |
Zeldis received $3.9M in option awards, accounting for 91% of the total pay in 2021.
Zeldis also received $396K in salary and $9.8K in other compensation.
Rankings
In 2021, Jerome Zeldis' compensation ranked 3,054th out of 12,415 executives tracked by ExecPay. In other words, Zeldis earned more than 75.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,054 out of 12,415 | 75th |
Division Manufacturing | 1,219 out of 5,508 | 78th |
Major group Chemicals And Allied Products | 488 out of 2,378 | 80th |
Industry group Drugs | 431 out of 2,099 | 80th |
Industry Pharmaceutical Preparations | 293 out of 1,549 | 81st |
Source: SEC filing on April 4, 2023.
Zeldis' colleagues
We found three more compensation records of executives who worked with Jerome Zeldis at NexImmune in 2021.